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Systematic Recruitment Methods 
 
• Our research programme has been adopted by the UK Mental Health Research 
  Network (MHRN). 
 
• We have obtained ethical approval and NHS R&D approval to recruit research participants 
across 30 NHS mental health trusts and health boards throughout the UK. 
 
• MHRN-employed Clinical Studies Officers (CSOs) liaise with mental health professionals to   
  identify potential participants. 
Introduction 
• Bipolar disorder (manic depressive illness) is a common (~1% lifetime risk) psychiatric disorder  
 with episodes of extreme mood disturbance ranging from mania to depression. 
 
• We are currently collecting clinically rich data from a large group of individuals with bipolar  
  disorder as part of our ongoing research into the genetic and environmental causes of bipolar  
  disorder. 
 
• Our aim is to recruit 6000 unrelated individuals with bipolar disorder and to conduct  
  thorough psychiatric assessments on all participants.  
 
Kay Redfield Jamison (Professor of Psychiatry and has bipolar disorder) ‘Depression is awful beyond words…it bleeds relationships through suspicion, lack of confidence and self respect, the inability to enjoy life, or 
walk or talk or think normally, the exhaustion… Depression is flat, hollow, unendurable.’  ‘When you’re high its tremendous. The ideas and feelings are fast… shyness goes… feelings of ease, intensity, power, well-
being, omnipotence and euphoria…But somewhere, this changes. The fast ideas become too fast…overwhelming confusion replaces clarity.’  An Unquiet Mind, A Memoir of Moods and Madness (1996) 
Assessing The Bipolar Phenotype 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future Work 
 
• We aim to continue to recruit to our study through our existing recruitment methods and are 
confident that with the help of the MHRN we will reach our 6000 participant target. 
Research assistants travel all across the UK to visit research participants in their homes 
Rich phenotype data is essential for molecular genetic studies 
investigating genotype-phenotype correlations 
A semi-structured psychiatric interview, 
Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN) is  
administered (~1.5 hrs). Each interview                
is recorded and frequently reliability meetings 
are held to ensure high inter-rater reliability.  
Self-rated  
questionnaires to 
measure 
psychological 
aspects of illness 
(endophenotypes) 
Small blood sample 
collected (2 tubes) 
DNA extracted 
Participants’ medical notes are 
accessed to supplement information 
provided at interview  
     We are looking for individuals who: 
 
    are over the age of 18. 
 
    have had one or more episodes of mania or hypomania at      
       any time that has lasted longer than 4 days. Participants 
       may have, or may have had, a diagnosis of bipolar I disorder, 
       bipolar II disorder or schizoaffective disorder. 
 
    are able to speak English fluently due to the semi-structured 
       nature of the interview. 
 
    are able to provide written informed consent. 
 
    are not known to have a blood-borne infection such as HIV. 
To help others 
• Many of our participants 
express concern about 
family members or other 
sufferers who may 
experience mental health 
problems in the future. They 
hope that their participation 
in our research will help 
lead to important advances 
in the diagnosis and 
treatment of mood disorders 
in the future. 
Interest in research 
• Participants are often keen 
to  take part in our study, 
recognising the significant 
impact that research can 
ultimately have on mental 
health practice. In some 
cases they may have 
participated in other projects 
or have been involved in  
research either through their 
work or academic studies. 
Generate awareness 
and reduce stigma 
• Participants often state that 
little is known about mood 
disorders in the community 
or workplace. Taking part in 
a large research project 
may generate awareness, 
improve others' 
understanding of mental 
health issues and hopefully 
reduce the stigma faced by 
those with a mental health 
problem. 
BDRN’s media 
involvement 
• Over the years our research 
has received extensive 
media coverage, featuring 
in a number of 
documentaries and radio 
programmes nationwide. 
Participants often cite this 
as a motivation for taking 
part in our research. 
Recruitment to Date 
 
• Since April 2006 the MHRN has helped us to recruit 1688 participants to the study across the UK.  
 
Two of our more famous participants: 
